214 related articles for article (PubMed ID: 23090113)
1. Development of amphotericin B-loaded cubosomes through the SolEmuls technology for enhancing the oral bioavailability.
Yang Z; Tan Y; Chen M; Dian L; Shan Z; Peng X; Wu C
AAPS PharmSciTech; 2012 Dec; 13(4):1483-91. PubMed ID: 23090113
[TBL] [Abstract][Full Text] [Related]
2. Oral administration of amphotericin B nanoparticles: antifungal activity, bioavailability and toxicity in rats.
Radwan MA; AlQuadeib BT; Šiller L; Wright MC; Horrocks B
Drug Deliv; 2017 Nov; 24(1):40-50. PubMed ID: 28155565
[TBL] [Abstract][Full Text] [Related]
3. Gelatin coated hybrid lipid nanoparticles for oral delivery of amphotericin B.
Jain S; Valvi PU; Swarnakar NK; Thanki K
Mol Pharm; 2012 Sep; 9(9):2542-53. PubMed ID: 22845020
[TBL] [Abstract][Full Text] [Related]
4. Amphotericin B loaded ethyl cellulose nanoparticles with magnified oral bioavailability for safe and effective treatment of fungal infection.
Kaur K; Kumar P; Kush P
Biomed Pharmacother; 2020 Aug; 128():110297. PubMed ID: 32480227
[TBL] [Abstract][Full Text] [Related]
5. Evaluating the potential of cubosomal nanoparticles for oral delivery of amphotericin B in treating fungal infection.
Yang Z; Chen M; Yang M; Chen J; Fang W; Xu P
Int J Nanomedicine; 2014; 9():327-36. PubMed ID: 24421641
[TBL] [Abstract][Full Text] [Related]
6. Biodegradable nanoparticles improve oral bioavailability of amphotericin B and show reduced nephrotoxicity compared to intravenous Fungizone.
Italia JL; Yahya MM; Singh D; Ravi Kumar MN
Pharm Res; 2009 Jun; 26(6):1324-31. PubMed ID: 19214716
[TBL] [Abstract][Full Text] [Related]
7. Oral bioavailability and stability study of a self-emulsifying drug delivery system (SEDDS) of amphotericin B.
Bhattacharyya A; Bajpai M
Curr Drug Deliv; 2013 Oct; 10(5):542-7. PubMed ID: 23675913
[TBL] [Abstract][Full Text] [Related]
8. Lyotropic Liquid Crystalline Nanoparticles of Amphotericin B: Implication of Phytantriol and Glyceryl Monooleate on Bioavailability Enhancement.
Jain S; Yadav P; Swami R; Swarnakar NK; Kushwah V; Katiyar SS
AAPS PharmSciTech; 2018 May; 19(4):1699-1711. PubMed ID: 29532426
[TBL] [Abstract][Full Text] [Related]
9. Formulation and development of bicontinuous nanostructured liquid crystalline particles of efavirenz.
Avachat AM; Parpani SS
Colloids Surf B Biointerfaces; 2015 Feb; 126():87-97. PubMed ID: 25543986
[TBL] [Abstract][Full Text] [Related]
10. Improved Oral Bioavailability and Gastrointestinal Stability of Amphotericin B through Fatty Acid Conjugation Approach.
Thanki K; Date T; Jain S
Mol Pharm; 2019 Nov; 16(11):4519-4529. PubMed ID: 31509418
[TBL] [Abstract][Full Text] [Related]
11. Solid lipid nanoparticles of amphotericin B (AmbiOnp): in vitro and in vivo assessment towards safe and effective oral treatment module.
Chaudhari MB; Desai PP; Patel PA; Patravale VB
Drug Deliv Transl Res; 2016 Aug; 6(4):354-64. PubMed ID: 26712123
[TBL] [Abstract][Full Text] [Related]
12. Amphotericin B Loaded Chitosan Nanoparticles: Implication of Bile Salt Stabilization on Gastrointestinal Stability, Permeability and Oral Bioavailability.
Jain S; Reddy CSK; Swami R; Kushwah V
AAPS PharmSciTech; 2018 Oct; 19(7):3152-3164. PubMed ID: 30136175
[TBL] [Abstract][Full Text] [Related]
13. Physical characterization and in vivo pharmacokinetic study of self-assembling amphotericin B-loaded lecithin-based mixed polymeric micelles.
Chen YC; Su CY; Jhan HJ; Ho HO; Sheu MT
Int J Nanomedicine; 2015; 10():7265-74. PubMed ID: 26664117
[TBL] [Abstract][Full Text] [Related]
14. Self-assembled liquid crystalline nanoparticles as a novel ophthalmic delivery system for dexamethasone: Improving preocular retention and ocular bioavailability.
Gan L; Han S; Shen J; Zhu J; Zhu C; Zhang X; Gan Y
Int J Pharm; 2010 Aug; 396(1-2):179-87. PubMed ID: 20558263
[TBL] [Abstract][Full Text] [Related]
15. Design of mannosylated oral amphotericin B nanoformulation: efficacy and safety in visceral leishmaniasis.
Sarwar HS; Sohail MF; Saljoughian N; Rehman AU; Akhtar S; Nadhman A; Yasinzai M; Gendelman HE; Satoskar AR; Shahnaz G
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):521-531. PubMed ID: 29385910
[TBL] [Abstract][Full Text] [Related]
16. Synergistic enhancement of parasiticidal activity of amphotericin B using copaiba oil in nanoemulsified carrier for oral delivery: an approach for non-toxic chemotherapy.
Gupta PK; Jaiswal AK; Asthana S; Teja B V; Shukla P; Shukla M; Sagar N; Dube A; Rath SK; Mishra PR
Br J Pharmacol; 2015 Jul; 172(14):3596-610. PubMed ID: 25825339
[TBL] [Abstract][Full Text] [Related]
17. Amphotericin B loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carrier (NLCs): physicochemical and solid-solution state characterizations.
Jansook P; Fülöp Z; Ritthidej GC
Drug Dev Ind Pharm; 2019 Apr; 45(4):560-567. PubMed ID: 30632399
[TBL] [Abstract][Full Text] [Related]
18. Formulation and optimization of nanoemulsion using antifungal lipid and surfactant for accentuated topical delivery of Amphotericin B.
Hussain A; Singh VK; Singh OP; Shafaat K; Kumar S; Ahmad FJ
Drug Deliv; 2016 Oct; 23(8):3101-3110. PubMed ID: 27854145
[TBL] [Abstract][Full Text] [Related]
19. Comparative studies on amphotericin B nanosuspensions prepared by a high pressure homogenization method and an antisolvent precipitation method.
Zhou Y; Fang Q; Niu B; Wu B; Zhao Y; Quan G; Pan X; Wu C
Colloids Surf B Biointerfaces; 2018 Dec; 172():372-379. PubMed ID: 30193196
[TBL] [Abstract][Full Text] [Related]
20. Topical Delivery of Erythromycin Through Cubosomes for Acne.
Khan S; Jain P; Jain S; Jain R; Bhargava S; Jain A
Pharm Nanotechnol; 2018; 6(1):38-47. PubMed ID: 29424323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
